Zimbabwe has declined a major US health deal valued at $367m (272 million pounds) spanning five years because of the United States' insistence on sensitive biological samples.
This move became public following a government memo from December was leaked, indicating that Head of State Emmerson Mnangagwa believed the agreement was "skewed".
An official representative later explained that the United States was requesting biological samples for scientific study and commercial purposes while refused to guarantee the resulting advantages from future medical innovations.
"We are forced to start the challenging and unfortunate process of ending our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had provided more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has urged further dialogue to secure a agreement acceptable to both sides so the country's vital HIV treatment initiative can be sustained.
Broader Background
Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a court blocked a similar deal with the US following legal challenges were raised about the security of citizens' medical information.
After resuming office recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
The agency had administered assistance for the US government, but Trump argued its spending was "wasteful" and his government was pursuing direct bilateral agreements to boost openness and accountability.
As per reports, Sixteen African countries have so far signed similar agreements, constituting over $18.3bn in committed funds.
Specifics of the Declined Agreement
The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"We believe this cooperation could have provided significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy via American-funded programmes," the Ambassador said.
However, official spokesman Nick Mangwana argued the arrangement was "unequal".
"The proposal required Zimbabwe to provide its genetic material and health information for a long time, with no equivalent guarantee of benefiting from any medical innovations – like new medicines or tests – that might result from that shared data," Mangwana explained.
"Put simply, our country would supply the basic resources for medical research without any assurance that the end products would be accessible to our people if a new disease outbreak emerge."
Sovereignty and Global Health
He also said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining frameworks previously set up through the global health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to manage potential pandemics.
"This system is designed to ensure that when a nation contributes its information, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to develop them."
The government's concerns over the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We welcome further discussions with our American counterparts on how future collaboration might be structured in a manner that honours the independence and dignity of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but urged that negotiations must proceed considering much of the country's Aids initiatives relied on external financing.
"If technical issues exist, including those involving data governance or agreement terms, these can frequently be resolved through detailed discussion and mutually agreed protections," the group commented.
The situation highlights the ongoing challenges between receiving vital foreign assistance and protecting national sovereignty in an ever more data-driven world.